Investor mix
5 investors on record; lead investors include BiGEN, Binex, Dai-Ichi Life, Shibuya Kogyo.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 20% |
| Other / undisclosed | 4 | 80% |
Developer of next-gen CAR-T immunotherapy platform for solid tumors
5 investors on record; lead investors include BiGEN, Binex, Dai-Ichi Life, Shibuya Kogyo.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 20% |
| Other / undisclosed | 4 | 80% |